Nikolaos A. Trikalinos

MedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors”.

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers

Journal of Clinical Epidemiology(2008)10.1016/j.jclinepi.2007.11.019

N/A

0.654DataRank · unranked

77 citations

Evangelos Evangelou, John P. A. Ioannidis, Nikolaos A. Trikalinos

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0.500DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)

Seminars in Oncology(2023)10.1053/j.seminoncol.2023.01.001

N/A

0.432DataRank · unranked

7 citations

David M. Zahrieh, Jun He, Blake Waechter, Julianne L. Holleran, Lionel D. Lewis +9 more

Therapeutic interventions for childhood cancer: An umbrella review of randomized evidence

Critical Reviews in Oncology/Hematology(2021)10.1016/j.critrevonc.2021.103414

N/A

0.387DataRank · unranked

6 citations

Georgios Markozannes, Orestis A. Panagiotou, Nikolaos A. Trikalinos, Eleni Petridou, Kirsten Voorhies +2 more

Supportive interventions for childhood cancer: An umbrella review of randomized evidence

Critical Reviews in Oncology/Hematology(2022)10.1016/j.critrevonc.2022.103845

N/A

0DataRank · unranked

3 citations

Georgios Markozannes, Kirsten Voorhies, Nikolaos A. Trikalinos, Eleni Petridou, Orestis A. Panagiotou +2 more

A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3104

N/A

0DataRank · unranked

3 citations

W. Kimryn Rathmell, Geoffrey I. Shapiro, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A. Trikalinos +9 more

Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer

Oncotarget(2021)10.18632/oncotarget.27896

N/A

0DataRank · unranked

11 citations

Kumar S. Bishnupuri, Iván González, Nikolaos A. Trikalinos, Ling Chen, Brian K. Dieckgraefe +1 more

Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.101774

N/A

0DataRank · unranked

5 citations

Elizabeth Wulff‐Burchfield, Pamela Egan, Lee A. Hugar, Ami Vyas, Nikolaos A. Trikalinos +6 more

1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2340

N/A

0DataRank · unranked

1 citations

T. Zemla, Susan M. Geyer, Jonathan Strosberg, Þorvarður R. Hálfdánarson, Nikolaos A. Trikalinos +13 more

Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4146

N/A

0DataRank · unranked

1 citations

Kian-Huat Lim, Robert R. McWilliams, Rama Suresh, A. Craig Lockhart, Amberly Brown +15 more

Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based Study

Preprints.org(2025)10.20944/preprints202501.0863.v1

N/A

0DataRank · unranked

0 citations

Elizabeth Wulff‐Burchfield, Pamela Egan, Lee A. Hugar, Ami Vyas, Nikolaos A. Trikalinos +6 more